Showing results (1281-1290 of 2,609) with videos related to
Sort By:
Pageof 261
Oncology Research|August 6, 2003
Synthesis and antiproliferative activity of basic ethers of 1,2-dihydropyrrolo[1,2-a]indole, 6H-isoindolo[2,1-a]indole, and 6H-benz[5,6]isoindolo[2,1-a]indoleJean Guillaumel, Stéphane Léonce, Alain Pierré, et al.Oncology Research|January 1, 1992
Resistance mechanisms to topoisomerase poisons: the application of cell culture methodsB C Baguley, G J Finlay, L M ChingOncology Research|January 1, 1992
Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cellsR Mazzanti, J M Croop, Z Gatmaitan, et al.Oncology Research|January 1, 1992
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I contentR D Woessner, W K Eng, G A Hofmann, et al.Oncology Research|January 1, 1992
The distribution of immunoreactive topoisomerase II Protein in human tissues and neoplasmsJ A Holden, D H Rolfson, C T WittwerOncology Research|October 14, 2010
The estrogen receptors in the papillary carcinoma of the thyroid glandMichael Vaiman, Youlian Olevson, Liliana Habler, et al.Oncology Research|October 14, 2010
Survivin-3B gene decreases the invasion-inhibitory effect of colon cancer cells with 5-fluorouracilKatsuji Sawai, Takanori Goi, Yasuo Hirono, et al.Oncology Research|October 14, 2010
Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumorsCong-Jun Wang, Hui Zhang, Kun Chen, et al.Oncology Research|December 15, 2010
RON and cisplatin resistance in ovarian cancer cell linesSilvia Prislei, Marisa Mariani, Giuseppina Raspaglio, et al.Oncology Research|December 15, 2010
Beta-adrenergic receptors in cancer: therapeutic implicationsMario Pérez-Sayáns, José Manuel Somoza-Martín, Francisco Barros-Angueira, et al.Pageof 261